Repeated Low-level Red-light Therapy: The Next Wave in Myopia Management?
- PMID: 37890098
- DOI: 10.1097/OPX.0000000000002083
Repeated Low-level Red-light Therapy: The Next Wave in Myopia Management?
Abstract
Exposure to long-wavelength light has been proposed as a potential intervention to slow myopia progression in children. This article provides an evidence-based review of the safety and myopia control efficacy of red light and discusses the potential mechanisms by which red light may work to slow childhood myopia progression.The spectral composition of the ambient light in the visual environment has powerful effects on eye growth and refractive development. Studies in mammalian and primate animal models (macaque monkeys and tree shrews) have shown that daily exposure to long-wavelength (red or amber) light promotes slower eye growth and hyperopia development and inhibits myopia induced by form deprivation or minus lens wear. Consistent with these results, several recent randomized controlled clinical trials in Chinese children have demonstrated that exposure to red light for 3 minutes twice a day significantly reduces myopia progression and axial elongation. These findings have collectively provided strong evidence for the potential of using red light as a myopia control intervention in clinical practice. However, several questions remain unanswered. In this article, we review the current evidence on the safety and efficacy of red light as a myopia control intervention, describe potential mechanisms, and discuss some key unresolved issues that require consideration before red light can be broadly translated into myopia control in children.
Copyright © 2023 American Academy of Optometry.
Conflict of interest statement
Conflict of Interest Disclosure: None of the authors have reported a financial conflict of interest. There was no sponsorship for the submitted review.
References
-
- Holden BA, Fricke TR, Wilson DA, et al. Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050. Ophthalmology 2016;123:1036–42.
-
- Flitcroft DI, He M, Jonas JB, et al. IMI—Defining and Classifying Myopia: A Proposed Set of Standards for Clinical and Epidemiologic Studies. Invest Ophthalmol Vis Sci 2019;60:M20–30.
-
- World Council of Optometry. Resolution: The Standard of Care for Myopia Management by Optometrists; 2021. Available at: https://worldcouncilofoptometry.info/resolution-the-standard-of-care-for... . Accessed March 21, 2023.
-
- Haarman AEG, Enthoven CA, Tideman JWL, et al. The Complications of Myopia: A Review and Meta-analysis. Invest Ophthalmol Vis Sci 2020;61:49.
-
- Rose K, Harper R, Tromans C, et al. Quality of Life in Myopia. Br J Ophthalmol 2000;84:1031–4.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources